References
- C. Schmidt, R. Wenz, B. Nies and F. Moll, Antibiotic in vivo/in vitro release, histocompatibility and biodegradation of gentamycin implants on lactic acid polymers and copolymers, J. Control. Rel. 37 (1995) 83-94; DOI: 10.1016/0168-3659(95)00067-1.
- M.E.A. Mamun, H.A. Khan, I. Dewan and R.U. Jalil, In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants, Pak. J. Pharm. Sci. 22 (2009) 360-367.
- M. Ramchandani and D. Robinson, In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants, J. Control. Rel. 54 (1998) 167-175; DOI: 10.1016/s0168-3659(97)00113-2.10.1016/S0168-3659(97)00113-2
- P.Y. Wang, C.X. Song, H.F. Sun, H.L. Shi and R.W. Shi, A biodegradable long-term contraceptive implant, Eng. Med. Biol. Soc. 6 (1998) 2901-2904; DOI: 10.1109/IEMS.1998.746093.
- http://www.surgistrategies.com/hotnews/baxter-agreement-with-innocall-implant.html
- C. Guse, S. Koennings, F. Kreye, F. Siepmann, A. Goepferich and J. Siepmann, Drug release from lipid-based implants: Elucidation of the underlying mass transport mechanisms, Int. J. Pharm. 314 (2006) 137-144; DOI: 10.1016/j.i.jpharm.2005.08.030.
- J.C. Shah and S. Allababidi, Glyceryl Monostearate Based Biodegradable Implants for Site Specific Delivery of Drugs, U.S. Pat. 5,891,456, 6 Apr 1999; ref. Chem. Abstr. 130 (1999) 271997f.
- United States Pharmacopoeia 30, National Formulary 25, United State Pharmacopeial Convection, Rockville 2007, pp. 1759-1760.
- S. Allababidi and J. Shah, Kinetic and mechanism of release from glyceryl monostearate based implants: Evaluation of release in a gel simulating in vivo implantations, J. Pharm. Sci. 87 (1998) 169-172; DOI: 10.1021/js9703986.10.1021/js9703986
- ICH Harmonised Tripartite Guideline, Stability Testing of New Drug Substances and Products, Q1A (R2), Current Step 4 version, 6 February 2003.
- P. Costa and J.M.S. Lobo, Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 13 (2001) 123-133.10.1016/S0928-0987(01)00095-1